Paper41226697
Modeling Glioblastoma with Brain Organoids: New Frontiers in Oncology and Space Research.
Begani L and 13 others. Int J Mol Sci, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Modeling Glioblastoma with Brain Organoids: New Frontiers in Oncology and Space Research. Papers, record 41226697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41226697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Modeling Glioblastoma with Brain Organoids: New Frontiers in Oncology and Space Research.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Organoids | Major topic |
| Glioblastoma | Major topic |
| Brain Neoplasms | Major topic |
| Brain | Major topic |
| Humans | |
| Animals | |
| Tumor Microenvironment | |
| Models, Biological |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RC2025 | Italian Ministry of Health | PubMed | ||
| GR-2019-12370940 | Italian Ministry of Health | PubMed | ||
| PNRM 2020 | Italian Ministry of Defense | PubMed |
Source PubMed
References69
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30820814 | Simulated microgravity inhibits the viability and migration of glioma via FAK/RhoA/Rock and FAK/Nek2 signaling. | In Vitro Cell Dev Biol Anim | 2019 | https://conductscience.org/library/papers/30820814 | PubMed |
| 2 | 20129251 | Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. | Cancer Cell | 2010 | https://conductscience.org/library/papers/20129251 | PubMed |
| 3 | 32905502 | Organoid models of glioblastoma: advances, applications and challenges. | Am J Cancer Res | 2020 | https://conductscience.org/library/papers/32905502 | PubMed |
| 4 | 32102932 | Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastoma. | Sci Transl Med | 2020 | https://conductscience.org/library/papers/32102932 | PubMed |
| 5 | 31519690 | Experimental models and tools to tackle glioblastoma. | Dis Model Mech | 2019 | https://conductscience.org/library/papers/31519690 | PubMed |
| 6 | 29052807 | Current trends in mouse models of glioblastoma. | J Neurooncol | 2017 | https://conductscience.org/library/papers/29052807 | PubMed |
| 7 | 37355636 | On the origin and development of glioblastoma: multifaceted role of perivascular mesenchymal stromal cells. | Acta Neuropathol Commun | 2023 | https://conductscience.org/library/papers/37355636 | PubMed |
| 8 | 36432580 | Physiological Alterations in Relation to Space Flight: The Role of Nutrition. | Nutrients | 2022 | https://conductscience.org/library/papers/36432580 | PubMed |
| 9 | 28104906 | Interrogating open issues in cancer precision medicine with patient-derived xenografts. | Nat Rev Cancer | 2017 | https://conductscience.org/library/papers/28104906 | PubMed |
| 10 | 34070023 | In Vitro Glioblastoma Models: A Journey into the Third Dimension. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34070023 | PubMed |
| 11 | 38732975 | Biosensor-Enhanced Organ-on-a-Chip Models for Investigating Glioblastoma Tumor Microenvironment Dynamics. | Sensors (Basel) | 2024 | https://conductscience.org/library/papers/38732975 | PubMed |
| 12 | 33364198 | Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy. | Front Oncol | 2020 | https://conductscience.org/library/papers/33364198 | PubMed |
| 13 | 37793125 | CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020. | Neuro Oncol | 2023 | https://conductscience.org/library/papers/37793125 | PubMed |
| 14 | 28945830 | Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors. | Ann Oncol | 2017 | https://conductscience.org/library/papers/28945830 | PubMed |
| 15 | 33585240 | Evolution of Experimental Models in the Study of Glioblastoma: Toward Finding Efficient Treatments. | Front Oncol | 2020 | https://conductscience.org/library/papers/33585240 | PubMed |
| 16 | 26896279 | A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo. | Cancer Res | 2016 | https://conductscience.org/library/papers/26896279 | PubMed |
| 17 | 35922758 | Characterization and comparison of human glioblastoma models. | BMC Cancer | 2022 | https://conductscience.org/library/papers/35922758 | PubMed |
| 18 | 16697959 | Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. | Cancer Cell | 2006 | https://conductscience.org/library/papers/16697959 | PubMed |
| 19 | 31148598 | A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy. | Nat Biomed Eng | 2019 | https://conductscience.org/library/papers/31148598 | PubMed |
| 20 | 14522905 | Identification of a cancer stem cell in human brain tumors. | Cancer Res | 2003 | https://conductscience.org/library/papers/14522905 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42905557 | Multi-omics and spatial analysis of microgravity-grown glioblastoma organoids reveal superior modeling of advanced disease after long-term spaceflight. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/42905557 | PubMed |
| 42796617 | In Vitro Effects of an Olive Polyphenol-Bromelain Formulation on U87MG Glioblastoma Cells: Viability, Cell-Cycle Distribution, Cytokine Release, and Total Antioxidant Capacity. | Molecules | 2026 | https://conductscience.org/library/papers/42796617 | PubMed |
| 41521070 | Vascularised Brain Organoids: Engineering Strategies and Neurobiological Applications. | Cell Prolif | 2026 | https://conductscience.org/library/papers/41521070 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41226697
GET https://conductscience.org/api/papers/v1/41226697/references?page=2